Perspectives on Adherence From the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach With 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment
ACTG 5360 MINMON试验中关于依从性的观点:慢性丙型肝炎治疗中采用12周索非布韦/维帕他韦治疗的最低限度监测方案
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciad034
Sowah, Leonard A; Smeaton, Laura; Brates, Irena; Bhattacharya, Debika; Linas, Benjamin; Kreter, Bruce; Wagner-Cardoso, Sandra; Solomon, Sunil; Sulkowski, Mark; Robbins, Gregory K